(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Pyramid Oil Co (AMEX:PDO), GlobalSCAPE Inc (AMEX:GSB), Asure Software Inc (NASDAQ:ASUR), Merriman Holdings Inc (OTC:MERR), Celldex Therapeutics Inc (NASDAQ:CLDX), Zalicus Inc (NASDAQ:ZLCS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date
PDO Pyramid Oil Co 13.98% 90.91% (10 of 11) Friday, December 28th 2012
GSB GlobalSCAPE Inc 11.92% 90.00% (9 of 10) Monday, January 7th 2013
ASUR Asure Software Inc 15.97% 75.00% (9 of 12) Tuesday, January 1st 2013
MERR Merriman Holdings Inc 14.74% 75.00% (9 of 12) Monday, January 7th 2013
CLDX Celldex Therapeutics Inc 15.26% 91.67% (11 of 12) Thursday, January 10th 2013
ZLCS Zalicus Inc 22.95% 85.71% (6 of 7) Friday, January 25th 2013
Pyramid Oil Co (AMEX:PDO) - Pyramid Oil Company engages in the exploration, development, and production of crude oil and natural gas resources. It operates 27 oil and gas leases located in the Kern and Santa Barbara counties in the State of California. The company sells oil and gas primarily to crude oil purchasers, refineries, or pipeline companies. Pyramid Oil Company was founded in 1909 and is based in Bakersfield, California..
GlobalSCAPE Inc (AMEX:GSB) - GlobalSCAPE, Inc. develops, distributes, and maintains secure managed file transfer software that enables individuals and business users to exchange information over the Internet, as well as wide-area file system (WAFS) collaboration and continuous data protection (CDP) software. The company offers file transfer protocol (FTP) client programs, including CuteFTP, which permits a user to request a file from or send a file to an FTP server or host computer; and CuteFTP Pro, a program that incorporates various standards for encrypting data during transport and at rest, accelerating transfer of large files, and automating common file transfer tasks. It also provides file transfer servers programs, such as Enhanced File Transfer Server, which provides digital certificate management, remote management capability, and ability to manage user accounts with settings for security and control; and Enhanced File Transfer Server Enterprise, an enterprise file server that supports enterprise installations. In addition, the company offers data replication products, including Wide Area File Services, which delivers a file access system, instant file-sharing, and server-to-server mirroring; and continuous backup software that delivers real-time continuous data protection. Further, it provides Mail Express, a software add-in that redirects email attachments for delivery in accordance with administrator-defined policies; and CuteSendIt, a software-as-a-service managed file transfer solution, as well as resells BOUNCER, an enterprise application whitelisting solution. GlobalSCAPE serves finance, health care, energy, retail, manufacturing, and engineering markets worldwide. The company was founded in 1996 and is based in San Antonio, Texas..
Asure Software Inc (NASDAQ:ASUR) - Asure Software, Inc. provides workforce management software and services. Its software empowers small to mid-size organizations and divisions of large enterprises to operate efficiently, increase worker productivity, and reduce costs. The company offers products that optimize workforce time and attendance tracking, benefits enrollment and tracking, pay stubs and W2 documentation, and meeting and event management. It was formerly known as Forgent Networks, Inc. and changed its name to Asure Software, Inc. in December 2009. The company was founded in 1985 and is headquartered in Austin, Texas with additional offices in Warwick, Rhode Island, Vancouver, and British Columbia, as well as in Mumbai, India..
Merriman Holdings Inc (OTC:MERR) - Merriman Holdings, Inc., through its subsidiary, Merriman & Co., provides investment banking, capital markets services, and corporate and venture services to institutional investors and corporate clients primarily in the United States and Canada. Its investment banking services include advising on and structuring capital raising solutions for corporate clients through public and private offerings of primarily equity and convertible debt securities. The companys investment banking services also comprise strategic advisory services consisting of transaction-specific advice regarding mergers and acquisitions, divestitures, spin-offs, and privatizations, as well as general strategic advice. In addition, it offers institutional brokerage services, including institutional sales, sales trading, and trading services, as well as executes securities transactions for money managers, mutual funds, hedge funds, insurance companies, and pension and profit-sharing plans. Additionally, the company provides corporate and executive services; venture services, including distribution and liquidity programs, portfolio company advisory services, research dissemination, and execution trading; OTCQX advisory services; and institutional cash distributors services. Further, it offers equity research services for the clean energy; consumer, media, and Internet; health care; and technology sectors. The company was formerly known as Merriman Curhan Ford Group, Inc. and changed its name to Merriman Holdings, Inc. on August 16, 2010. Merriman Holdings was founded in 1987 and is headquartered in San Francisco, California..
Celldex Therapeutics Inc (NASDAQ:CLDX) - Celldex Therapeutics, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of targeted immunotherapies that prevent or treat specific forms of cancer, autoimmune disorders, and diseases caused by infectious organisms. Its precision targeted immunotherapy platform includes a portfolio of monoclonal antibodies, antibody-targeted vaccines, antibody-drug conjugates, and immunomodulators to create disease-specific drug candidates. The company offers Rotarix for the treatment of rotavirus infection. Its clinical development programs include CDX-110, which is in Phase IIb clinical trail for the treatment of glioblastoma multiforme; CDX-011 that is in Phase II clinical trial to treat metastatic melanoma and breast cancer; and CDX-1307, a Phase I clinical trial product for treating colorectal, bladder, pancreas, ovarian, and breast tumors, as well as CDX-1401 and CDX-1135, which are in Phase I/II clinical trials for the treatment of multiple solid tumors and renal diseases respectively. The companys preclinical product candidates comprise CDX-301 for treating cancer, and autoimmune diseases and transplants; CDX-1127 for immuno-modulation and multiple tumors; CDX-014 to treat renal and ovarian cancer; and CDX-1189 for renal diseases. It has collaborative partnership agreements with GlaxoSmithKline plc; Pfizer Inc.; Vaccine Technologies, Inc.; and TopoTarget A/S, as well as research collaboration and licensing agreements with Medarex, Inc.; Alteris Therapeutics, Inc.; 3M Company; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. The company was founded in 1983 and is headquartered in Needham, Massachusetts..
Zalicus Inc (NASDAQ:ZLCS) - Zalicus Inc., a biopharmaceutical company, discovers and develops drug candidates focusing on the treatment of pain and inflammation. The company' s clinical and preclinical product candidates include Synavive, a glucocorticoid prednisolone product candidate, which is in Phase IIb clinical trial for the treatment of rheumatoid arthritis; Z160, an N-type calcium channel blocker that has completed Phase I clinical trial to treat neuropathic and inflammatory pain; and Z944, an oral T-type calcium channel blocker, which is in Phase I clinical trial for the treatment of various chronic pain conditions, as well as sodium channels to treat acute and chronic inflammatory, and neuropathic pain. It has research collaboration agreement with Hydra Biosciences, Mallinckrodt Inc., and Amgen Inc.; research and license agreement with Fovea Pharmaceuticals SA and Novartis; and cooperative research and development agreement with the United States Army Medical Research Institute for Infectious Diseases. The company was formerly known as CombinatoRx, Incorporated and changed its name to Zalicus Inc. in September 2010. Zalicus Inc. was founded in 2000 and is based in Cambridge, Massachusetts..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com)).